Moxiture

(Amoxicillin 500 mg, Clavulanic Acid 125 mg)

Moxture is a reliable range of Amoxicillin-based formulations combined with Clavulanic Acid and other supportive agents, designed to deliver superior efficacy in the treatment of bacterial infections. Backed by clinical research and advanced formulation technology, Moxture ensures enhanced safety, better tolerance, and faster recovery.

Available Formulations:

• Moxture 250 DT – Amoxicillin 250 mg DT Tablets
• Moxture 500 – Amoxicillin 500 mg Capsules
• Moxture CL – Amoxicillin + Potassium Clavulanate (Injections, Tablets, Dry Syrup)
• Moxture CL DDS – Amoxicillin Trihydrate + Potassium Clavulanate Suspension
• Moxture CL 625 LB – Amoxicillin 500 mg + Clavulanic Acid 125 mg + Lactobacillus 60 million spores Tablets
• Moxture Dry Syrup – Amoxicillin 125 mg/5ml (Pediatric use)

Indications:

• Moxiture is indicated in the treatment of Skin & Soft Tissue Infections, Dental Infections, Respiratory Tract Infections (Upper & Lower RTI, Bronchitis, Sinusitis), Pneumonia (Community Acquired), Acute Otitis Media (AOM), Tonsillitis & Pharyngitis, Urinary Tract Infections (U.T.I), Surgical Prophylaxis (Comprehensive choice in abdominal & gynecological surgery).

Product Descriptions of Calciture:

• Broad-Spectrum Action – Effective against both Gram-positive & Gram-negative bacteria
• Enhanced Clinical Efficacy – Combats resistant bacterial strains with Clavulanic Acid support
• Improved Safety Profile – Reduced risk of gastrointestinal disturbances with probiotic combination (Lactobacillus)
• Versatile Coverage – Trusted choice in multiple bacterial infections
• Pediatric & Adult Variants – Wide availability for all age groups